Nevro Corp. (NVRO) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Nevro Corp. (NVRO) Bundle
Enhance your investment choices with the Nevro Corp. (NVRO) DCF Calculator! Utilize authentic financial data for Nevro, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Nevro Corp. (NVRO).
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 390.3 | 362.0 | 386.9 | 406.4 | 425.2 | 494.6 | 575.2 | 669.1 | 778.3 | 905.3 |
Revenue Growth, % | 0 | -7.23 | 6.87 | 5.03 | 4.63 | 16.32 | 16.32 | 16.32 | 16.32 | 16.32 |
EBITDA | -83.4 | -52.2 | -102.4 | 21.0 | -78.3 | -74.7 | -86.9 | -101.0 | -117.5 | -136.7 |
EBITDA, % | -21.36 | -14.42 | -26.47 | 5.17 | -18.42 | -15.1 | -15.1 | -15.1 | -15.1 | -15.1 |
Depreciation | 7.8 | 8.2 | 8.7 | 10.3 | 11.5 | 11.6 | 13.5 | 15.7 | 18.3 | 21.3 |
Depreciation, % | 2 | 2.26 | 2.24 | 2.54 | 2.71 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 |
EBIT | -91.2 | -60.4 | -111.1 | 10.7 | -89.8 | -86.3 | -100.4 | -116.8 | -135.8 | -158.0 |
EBIT, % | -23.36 | -16.68 | -28.71 | 2.63 | -21.13 | -17.45 | -17.45 | -17.45 | -17.45 | -17.45 |
Total Cash | 237.8 | 588.0 | 362.0 | 374.4 | 322.7 | 417.9 | 486.1 | 565.4 | 657.7 | 765.0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 82.8 | 77.7 | 70.5 | 78.9 | 79.4 | 97.9 | 113.9 | 132.5 | 154.1 | 179.2 |
Account Receivables, % | 21.23 | 21.45 | 18.22 | 19.42 | 18.67 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 |
Inventories | 91.6 | 83.3 | 93.5 | 99.6 | 118.7 | 121.7 | 141.6 | 164.7 | 191.6 | 222.8 |
Inventories, % | 23.47 | 23.01 | 24.17 | 24.52 | 27.91 | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 |
Accounts Payable | 13.7 | 23.1 | 32.0 | 26.8 | 22.5 | 29.7 | 34.6 | 40.2 | 46.8 | 54.4 |
Accounts Payable, % | 3.51 | 6.38 | 8.27 | 6.61 | 5.3 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 |
Capital Expenditure | -3.5 | -6.0 | -12.3 | -7.5 | -8.6 | -9.5 | -11.1 | -12.9 | -15.0 | -17.4 |
Capital Expenditure, % | -0.88967 | -1.66 | -3.19 | -1.86 | -2.02 | -1.92 | -1.92 | -1.92 | -1.92 | -1.92 |
Tax Rate, % | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 |
EBITAT | -92.6 | -61.0 | -111.5 | 7.5 | -84.7 | -80.2 | -93.3 | -108.5 | -126.2 | -146.8 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -249.0 | -36.0 | -109.3 | -9.4 | -105.5 | -92.4 | -121.8 | -141.7 | -164.8 | -191.7 |
WACC, % | 6.1 | 6.1 | 6.1 | 5.28 | 5.94 | 5.91 | 5.91 | 5.91 | 5.91 | 5.91 |
PV UFCF | ||||||||||
SUM PV UFCF | -590.0 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | -199 | |||||||||
Terminal Value | -10,452 | |||||||||
Present Terminal Value | -7,845 | |||||||||
Enterprise Value | -8,435 | |||||||||
Net Debt | 118 | |||||||||
Equity Value | -8,552 | |||||||||
Diluted Shares Outstanding, MM | 36 | |||||||||
Equity Value Per Share | -237.69 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Nevro Corp.'s (NVRO) financial data pre-filled to expedite your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Data: Nevro Corp.’s (NVRO) extensive historical financial records and pre-filled forecasts.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Instantly view Nevro Corp.’s (NVRO) intrinsic value updates as you make changes.
- Intuitive Visualizations: Engaging dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Download the Template: Get instant access to the Excel-based NVRO DCF Calculator.
- Input Your Assumptions: Adjust yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically updates Nevro Corp.'s intrinsic value.
- Test Scenarios: Simulate different assumptions to evaluate potential valuation changes.
- Analyze and Decide: Use the results to guide your investment or financial analysis.
Why Choose This Calculator for Nevro Corp. (NVRO)?
- Designed for Experts: A sophisticated tool utilized by healthcare analysts, investors, and financial advisors.
- Comprehensive Data: Nevro’s historical and projected financials are preloaded for enhanced accuracy.
- Forecast Scenarios: Effortlessly simulate various financial forecasts and assumptions.
- Detailed Outputs: Automatically calculates intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance makes navigating the calculator straightforward.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Nevro Corp. (NVRO) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Nevro Corp. (NVRO).
- Consultants: Deliver professional valuation insights for Nevro Corp. (NVRO) to clients quickly and accurately.
- Business Owners: Understand how companies like Nevro Corp. (NVRO) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Nevro Corp. (NVRO).
What the Template Contains
- Pre-Filled Data: Includes Nevro Corp.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Nevro Corp.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.